In the liver, APPL1 potentiates the inhibitory effect of insulin on hepatic gluconeogenesis through activation of AKT protein kinases; APPL1 overexpression in the liver eliminates hyperglycemia in mice with diabetes. Here, APPL1 is linked to Hyperglycemia.